middle.news
Biome Advances IP Strategy with Patent Filing for Probiotic BMB18
9:27am on Monday 27th of April, 2026 AEST
•
Healthcare
Read Story
Biome Advances IP Strategy with Patent Filing for Probiotic BMB18
9:27am on Monday 27th of April, 2026 AEST
Key Points
Patent application lodged for proprietary probiotic BMB18
Randomised clinical trial to start in Q4 FY26 with 240 participants
Pre-clinical data shows immune modulation and antioxidant potential
Trial results to inform future product development and commercialisation
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Biome Australia (ASX:BIO)
OPEN ARTICLE